The Howard Hughes Medical Institute, The Children's Hospital, Immune Disease Institute, and Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America.
PLoS One. 2010 Nov 15;5(11):e13992. doi: 10.1371/journal.pone.0013992.
The 5' end of the IgH locus contains a cluster of DNaseI hypersensitive sites, one of which (HS1) was shown to be pro-B cell specific and to contain binding sites for the transcription factors PU.1, E2A, and Pax5. These data as well as the location of the hypersensitive sites at the 5' border of the IgH locus suggested a possible regulatory function for these elements with respect to the IgH locus. To test this notion, we generated mice carrying targeted deletions of either the pro-B cell specific site HS1 or the whole cluster of DNaseI hypersensitive sites. Lymphocytes carrying these deletions appear to undergo normal development, and mutant B cells do not exhibit any obvious defects in V(D)J recombination, allelic exclusion, or class switch recombination. We conclude that deletion of these DNaseI hypersensitive sites does not have an obvious impact on the IgH locus or B cell development.
IgH 基因座的 5' 端含有一组 DNaseI 超敏位点,其中一个(HS1)被证明是前 B 细胞特异性的,并且包含转录因子 PU.1、E2A 和 Pax5 的结合位点。这些数据以及超敏位点在 IgH 基因座 5' 边界的位置表明这些元件可能对 IgH 基因座具有调节功能。为了验证这一观点,我们生成了携带靶向缺失的前 B 细胞特异性位点 HS1 或整个 DNaseI 超敏位点簇的小鼠。携带这些缺失的淋巴细胞似乎经历了正常的发育,并且突变 B 细胞在 V(D)J 重组、等位基因排斥或类别转换重组中没有表现出任何明显的缺陷。我们得出结论,这些 DNaseI 超敏位点的缺失对 IgH 基因座或 B 细胞发育没有明显影响。